BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
140 results:

  • 1. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
    Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
    Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutational signatures for breast cancer diagnosis using artificial intelligence.
    Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
    J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
    Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X
    Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Longitudinal Analysis of cancer Risk in Children and Adults With Germline pten Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pten hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
    Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. cancer Risk Associated With
    Cummings S; Alfonso A; Hughes E; Kucera M; Mabey B; Singh N; Eng C
    JCO Precis Oncol; 2023 Jan; 7():e2200415. PubMed ID: 36634299
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and genetic diagnosis of Cowden syndrome: A case report of a rare pten germline variant and diverse clinical presentation.
    Arai H; Akagi K; Nakagawa A; Onai Y; Utsu Y; Masuda S; Aotsuka N
    Medicine (Baltimore); 2023 Jan; 102(1):e32572. PubMed ID: 36607858
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The yield and effectiveness of breast cancer surveillance in women with pten Hamartoma Tumor Syndrome.
    Hoxhaj A; Drissen MMCM; Vos JR; Bult P; Mann RM; Hoogerbrugge N
    Cancer; 2022 Aug; 128(15):2883-2891. PubMed ID: 36533707
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. breast incidentalomas on 18-Fluorodeoxyglucose positron emission tomography-computed tomography performed for a non-mammary cause: Significance and outcomes.
    Menon P; Bourke A
    J Med Imaging Radiat Oncol; 2023 Jun; 67(4):357-364. PubMed ID: 36468633
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A progressive and refractory case of breast cancer with Cowden syndrome.
    Sueta A; Takeno M; Goto-Yamaguchi L; Tomiguchi M; Inao T; Yamamoto-Ibusuki M; Yamamoto Y
    World J Surg Oncol; 2022 Sep; 20(1):279. PubMed ID: 36057718
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Ovarian Carcinosarcoma Associated with Cowden Syndrome-A Case Report].
    Higuchi D; Matsuura T; Takamine E; Hosokawa M; Kobori K; Ikeda S; Harada S; Honma K; Tajima A; Yoshida M; Otsuka I
    Gan To Kagaku Ryoho; 2022 Jul; 49(7):783-787. PubMed ID: 35851351
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer.
    Chavarri-Guerra Y; Villarreal-Garza C; Ferrigno AS; Mohar A; Aguilar D; Alvarez-Gomez RM; Gallardo-Alvarado L; Del Toro-Valero A; Quintero-Beulo G; Gutierrez-Delgado F; Rodriguez-Olivares JL; Ochoa-Chavez MF; Gutierrez-Seymour G; Castillo D; Herzog J; Weitzel JN
    Salud Publica Mex; 2022 Feb; 64(1):41-48. PubMed ID: 35438911
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
    Johansson A; Yu NY; Iftimi A; Tobin NP; van 't Veer L; Nordenskjöld B; Benz CC; Fornander T; Perez-Tenorio G; Stål O; Esserman LJ; Yau C; Lindström LS
    Int J Cancer; 2022 Jun; 150(12):2072-2082. PubMed ID: 35179782
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
    Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Enhanced immortalization, HUWE1 mutations and other biological drivers of breast invasive carcinoma in Black/African American patients.
    Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
    Gene; 2020 Dec; 763S():100030. PubMed ID: 34493366
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China.
    Liu X; Davis AA; Xie F; Gui X; Chen Y; Zhang Q; Gerratana L; Zhang Y; Shah AN; Behdad A; Wehbe F; Huang Y; Yu J; Du P; Jia S; Li H; Cristofanilli M
    Breast Cancer Res Treat; 2021 Nov; 190(2):213-226. PubMed ID: 34471951
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Penetrance of breast cancer Susceptibility Genes From the eMERGE III Network.
    Fan X; Wynn J; Shang N; Liu C; Fedotov A; Hallquist MLG; Buchanan AH; Williams MS; Smith ME; Hoell C; Rasmussen-Torvik LJ; Peterson JF; Wiesner GL; Murad AM; Jarvik GP; Gordon AS; Rosenthal EA; Stanaway IB; Crosslin DR; Larson EB; Leppig KA; Henrikson NB; Williams JL; Li R; Hebbring S; Weng C; Shen Y; Crew KD; Chung WK
    JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377931
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with breast cancer.
    Al-Shamsi HO; Abu-Gheida I; Abdulsamad AS; AlAwadhi A; Alrawi S; Musallam KM; Arun B; Ibrahim NK
    Oncologist; 2021 Nov; 26(11):e2086-e2089. PubMed ID: 34327780
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.
    Wijetunga NA; Dos Anjos CH; Zhi WI; Robson M; Tsai CJ; Yamada Y; Dover L; Gillespie EF; Xu AJ; Yang JT
    Cancer Med; 2021 Aug; 10(15):5163-5174. PubMed ID: 34159748
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.